LENSAR, Inc. (LNSR)

↓ Download CSV

CIK 0001320350 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, LENSAR, Inc. reported revenue of $51.66M, up 12.4% from the prior year. The company ran a net loss, with a net margin of -66.4%. It held $71.43M in total assets against $83.67M in total liabilities.

Key ratios (FY2025)

-47.6%
Operating margin
-66.4%
Net margin
+12.4%
Revenue growth (YoY)
Metric (FY)20252024202320222021202020192018
Revenue$51.66M$45.96M$35.72M$29.44M$29.49M$22.78M$26.35M
Cost of Revenue$31.31M$27.64M$21.06M$15.40M$16.63M$12.31M$17.30M
Operating Income-$24.58M-$10.66M-$12.23M-$20.18M-$19.65M-$18.50M-$12.71M
Net Income-$34.28M-$31.40M-$14.38M-$19.91M-$19.60M-$19.77M-$14.66M
EPS (Diluted)$-2.87$-2.73$-1.31$-1.96$-2.09
Total Assets$71.43M$66.30M$69.58M$55.84M$66.47M$79.12M$34.54M
Total Liabilities$83.67M$47.65M$22.41M$13.86M$11.59M$11.91M$65.09M
Shareholders' Equity-$26.02M$4.86M$33.43M$41.98M$54.88M$67.21M-$30.55M-$20.46M
Cash & Equivalents$12.97M$16.26M$20.62M$14.67M$31.64M$40.60M$4.62M
Operating Cash Flow-$14.83M-$2.27M-$9.66M-$14.86M-$8.97M-$13.79M-$12.59M
Capital Expenditures$83.0K$156.0K$236.0K$115.0K$354.0K$366.0K$389.0K
Shares Outstanding11.99M11.65M11.33M11.09M10.99M10.93M1.07M